Zobrazeno 1 - 10
of 122
pro vyhledávání: '"J. Dimitroulis"'
Publikováno v:
Oncology Letters. 4:1013-1016
Liposomal cisplatin (Lipoplatin) is a new agent, a cisplatin formulation that has been investigated in a number of studies and compared with cisplatin with respect to toxicity and effectiveness. It has been administered once weekly and in combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec64bd56c25d0443cae582a35d9a5da
https://doi.org/10.3892/ol.2012.836
https://doi.org/10.3892/ol.2012.836
Autor:
J. Dimitroulis, George P. Stathopoulos, K. Marosis, D. Antoniou, P. Michalopoulou, J. Stathopoulos
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose Liposomal cisplatin was developed to reduce the systemic toxicity of cisplatin, particularly the nephrotoxicity, and it has been used in combination with other agents in pancreatic and head and neck cancers and non-small-cell lung cancer (NSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5c66b90ba63f8688b80706d1ba27f6
https://doi.org/10.1007/s00280-011-1572-5
https://doi.org/10.1007/s00280-011-1572-5
Autor:
A. Athanasiou, G.P. Stathopoulos, Achilles Anagnostopoulos, J. Koutantos, J. Dimitroulis, Dimitrios T. Trafalis
Publikováno v:
Oncology Letters. 1:335-338
Erlotinib is an oral, small-molecule targeting therapy that inhibits epidermal growth factor tyrosine kinase receptors. Erlotinib has been administered for the treatment of advanced pancreatic cancer and non-small cell lung cancer. In the present tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2bbf43285c8336f486c984f9577015e
https://doi.org/10.3892/ol_00000059
https://doi.org/10.3892/ol_00000059
Autor:
D. Tsavdaridis, J. Stathopoulos, George P. Stathopoulos, P. Michalopoulou, J. Dimitroulis, C. Katis, D. Antoniou, C. Marosis, O. Armenaki, T. Grigoratou
Publikováno v:
British Journal of Cancer
Our purpose was to determine the efficacy of irinotecan plus paclitaxel administered on day 1, repeated every 2 weeks, in untreated patients with advanced or metastatic non-small-cell lung cancer (NSCLC). In total, 56 patients with inoperable or meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::218329364acf8cf4a096e48e120ad3ed
https://doi.org/10.1038/sj.bjc.6602827
https://doi.org/10.1038/sj.bjc.6602827
Autor:
Th. Giannakakis, J. Stathopoulos, D. Antoniou, D.V. Skarlos, S. K. Rigatos, George P. Stathopoulos, C. Christodoulou, O. Armenaki, J. Dimitroulis, K. Katis, N. Georgatou, P. Giamboudakis, Athanasios Athanasiadis
Publikováno v:
Cancer Chemotherapy and Pharmacology. 57:796-800
Purpose: Our main objective was to investigate the response rate in pretreated patients with small cell lung cancer (SCLC) who received a weekly administration of topotecan and paclitaxel; our secondary objectives were to assess toxicity and survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6cfff78f46ca4035f331de24e7a7a1
https://doi.org/10.1007/s00280-005-0085-5
https://doi.org/10.1007/s00280-005-0085-5
Publikováno v:
European Respiratory Journal. 17:1167-1174
The lack of methodology for measuring the alveolar carbon dioxide tension (PA,CO2) has forced investigators to make several assumptions, such as thatPA,CO2is equal to end-tidal (PET,CO2) and arterial CO2tension (Pa,CO2).The present study measured the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc544c031a60879a1b1c2b58d74e254
https://doi.org/10.1183/09031936.01.00063301
https://doi.org/10.1183/09031936.01.00063301
Autor:
J Dimitroulis, J. Jordanoglou, A Rassidakis, Mina Gaga, Joseph Milic-Emili, Panagiotis Rapakoulias, Nikolaos Koulouris
Publikováno v:
European Respiratory Journal. 10:2366-2370
In normal subjects and patients with airway obstruction, flows during a forced vital capacity (FVC) manoeuvre are higher after a fast inspiration without an end-inspiratory pause (manoeuvre 1) as compared to a slow inspiration with an end-expiratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da78ceab2c8da1f7f357becf50da652
https://doi.org/10.1183/09031936.97.10102366
https://doi.org/10.1183/09031936.97.10102366
Autor:
A. Rasidakis, D. Orphanidou, Mina Gaga, J. Jordanoglou, Manos Alchanatis, E Passalidou, Michail Toumbis, J Dimitroulis
Publikováno v:
Europe PubMed Central
Thymidine kinase (TK), carbohydrate antigen 19-9 (CA 19-9), carbohydrate antigen 125 (CA 125), squamous cell carcinoma antigen (SCC) and tissue polypeptide antigen (TPA), were evaluated in 104 untreated patients with primary lung cancer acid 55 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::520bd256e733570ab7eb669f399ada52
https://pubmed.ncbi.nlm.nih.gov/21597871
https://pubmed.ncbi.nlm.nih.gov/21597871
Autor:
Karatzas, T. Gompou, A. Bokos, J. Dimitroulis, D. Boletis, J. Kostakis, A. Kouraklis, G. Zavos, G.
Background The utilization of kidney grafts from expanded criteria donors (ECDs) needs to be evaluated within the context of critical organ shortage and graft function and survival. The impact of donor risk variables on kidney transplantation (KTx) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::2b3570d8f3c761847a27db94180aa024
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3129188
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3129188
Autor:
D. Antoniou, G. Tsoukalas, A. Provata, K. Marosis, D. Veldekis, P. Michalopoulou, Ch. Pappas, A. Bastas, J. Dimitroulis, M. Toubis, N. Georgatou, J. Stathopoulos, George P. Stathopoulos, P. Yiamboudakis, N. Lolis
Publikováno v:
Annals of Oncology
Background: Liposomal cisplatin is a new formulation developed to reduce the systemic toxicity of cisplatin while simultaneously improving the targeting of the drug to the primary tumor and to metastases by increasing circulation time in the body flu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c65f2dc3cea61a5fcaba99b06d0950c3
https://pubmed.ncbi.nlm.nih.gov/20439345
https://pubmed.ncbi.nlm.nih.gov/20439345